IPCA Laboratories Ltd consolidated Q1 FY23 PAT up QoQ at Rs. 143.06 crores

has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022 as compared to Rs. 1303.64 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 143.06 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 130.23 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 5.64 for the period ended June 30, 2022 as compared to Rs. 5.13 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 1607.85 crs	₹1303.64 crs	23.34%
Net Profit	₹143.06 crs	₹130.23 crs	9.85%
EPS	₹5.64	₹5.13	9.94%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022 as compared to Rs.1586.81 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.143.06 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.306.66 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.5.64 for the period ended June 30, 2022 as compared to Rs.12.09 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 1607.85 crs	₹1586.81 crs	1.33%
Net Profit	₹143.06 crs	₹306.66 crs	-53.35%
EPS	₹5.64	₹12.09	-53.35%

Source : Equity Bulls

Keywords

IPCALaboratories Q1FY23 ResultUpdate